Proper days after a capital-markets day left traders questioning what’s subsequent for Novo Nordisk, the Danish drug huge struck a licensing deal price over $1 billion…
Read More
After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring
Related Posts
‘We occupy been inappropriate.’ Why Morgan Stanley modified its tune on the U.S. buck — and what it expects now.
Rising bond yields and anticipated Fed rate hikes occupy wrecked...
The low-key California property portfolio of ‘Wednesday’ superstar Jenna Ortega
“Wednesday” superstar Jenna Ortega can also very neatly be one...
Akamai’s stock is surging. A $12 billion Anthropic deal reveals its extra special edge over cloud suppliers.
Akamai has agreed to develop cloud-computing companies to Anthropic…Read More